- Call for Independent Scientific Experts to Join EMA’s Pharmacovigilance Risk Assessment Committee
- How Different Forms of Liquid Biopsies Can Be Exploited to Guide Patient Care?
- FDA Approves Neratinib for Extended Adjuvant Treatment of Early Stage HER2-Positive Breast Cancer
- FDA ODAC Recommends Biosimilar Bevacizumab and Trastuzumab
- FDA Grants Priority Review for Abemaciclib in Advanced Breast Cancer
- FDA Clears Expanded Use of Cooling Cap to Reduce Hair Loss During Chemotherapy
- 1 of 2
- next ›